Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$757M |
| 2 |
Microsoft
MSFT
|
+$725M |
| 3 |
Apple
AAPL
|
+$628M |
| 4 |
Amazon
AMZN
|
+$487M |
| 5 |
Meta Platforms (Facebook)
META
|
+$355M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$121M |
| 2 |
KE Holdings
BEKE
|
+$31.8M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$24.4M |
| 4 |
X
US Steel
X
|
+$18.4M |
| 5 |
BERY
Berry Global Group, Inc.
BERY
|
+$15.6M |
Sector Composition
| 1 | Technology | 34.97% |
| 2 | Consumer Discretionary | 11.79% |
| 3 | Communication Services | 10.31% |
| 4 | Healthcare | 9.95% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Dyne Therapeutics
DYN
$1.87B
| $1.34M | ﹤0.01% |
140,400
+22,100
| +19% | +$210K |
|
|
NPKI
2002
NPK International Inc.
NPKI
$889M
| $1.34M | ﹤0.01% |
157,000
-2,500
| -2% | -$21.3K |
|
2003
Wave Life Sciences
WVE
$1.11B
| $1.33M | ﹤0.01% |
205,200
+13,200
| +7% | +$85.8K |
|
2004
Lifestance Health
LFST
$2.03B
| $1.33M | ﹤0.01% |
257,100
-4,300
| -2% | -$22.2K |
|
2005
Aris Water Solutions
ARIS
$787M
| $1.33M | ﹤0.01% |
56,100
+8,500
| +18% | +$201K |
|
2006
Business First Bancshares
BFST
$723M
| $1.32M | ﹤0.01% |
53,608
-800
| -1% | -$19.7K |
|
2007
eXp World Holdings
EXPI
$1.75B
| $1.32M | ﹤0.01% |
145,200
-3,600
| -2% | -$32.8K |
|
2008
Integral Ad Science
IAS
$1.4B
| $1.32M | ﹤0.01% |
158,700
| – | – |
|
2009
Excelerate Energy
EE
$770M
| $1.32M | ﹤0.01% |
44,900
+12,000
| +36% | +$352K |
|
2010
Independent Bank Corp
IBCP
$657M
| $1.31M | ﹤0.01% |
40,500
| – | – |
|
2011
Camden National
CAC
$684M
| $1.31M | ﹤0.01% |
32,261
+1,200
| +4% | +$48.7K |
|
2012
Montrose Environmental
MEG
$1.05B
| $1.31M | ﹤0.01% |
59,800
| – | – |
|
2013
HealthStream
HSTM
$855M
| $1.31M | ﹤0.01% |
47,200
| – | – |
|
2014
Horizon Bancorp
HBNC
$833M
| $1.3M | ﹤0.01% |
84,750
| – | – |
|
2015
Merchants Bancorp
MBIN
$1.5B
| $1.3M | ﹤0.01% |
39,400
-800
| -2% | -$26.5K |
|
2016
Douglas Dynamics
PLOW
$752M
| $1.3M | ﹤0.01% |
44,100
-1,200
| -3% | -$35.4K |
|
2017
Vestis
VSTS
$554M
| $1.3M | ﹤0.01% |
226,550
-3,000
| -1% | -$17.2K |
|
2018
Esquire Financial Holdings
ESQ
$828M
| $1.3M | ﹤0.01% |
13,700
| – | – |
|
2019
Praxis Precision Medicines
PRAX
$794M
| $1.3M | ﹤0.01% |
30,800
+3,700
| +14% | +$156K |
|
2020
Owens & Minor
OMI
$412M
| $1.29M | ﹤0.01% |
142,000
| – | – |
|
2021
Northeast Bank
NBN
$941M
| $1.29M | ﹤0.01% |
14,500
| – | – |
|
2022
Rumble
RUM
$2.48B
| $1.29M | ﹤0.01% |
143,600
+16,900
| +13% | +$152K |
|
2023
PROS Holdings
PRO
$699M
| $1.29M | ﹤0.01% |
82,200
+4,300
| +6% | +$67.3K |
|
2024
PDF Solutions
PDFS
$765M
| $1.28M | ﹤0.01% |
60,100
| – | – |
|
2025
FTAI Infrastructure
FIP
$518M
| $1.28M | ﹤0.01% |
208,200
+9,900
| +5% | +$61.1K |
|